U-Breathe Clinical Response to COVID-19 Pandemic
In response to COVID-19, my team at U-Breathe and I want to assure you that we are taking measures towards maintaining a safe environment for all our patients, staff, and physicians.
Journal Club - Nintedanib in Progressive Fibrosing ILDs
The annual rate of decline in the FVC in patients with progressive fibrosing Interstitial Lung Diseases was significantly lower among patients who received Nintedanib than placebo.
Journal Club - Stability of Blood EOS as COPD phenotype prediction
The use of blood eosinophil levels as a biomarker of exacerbation risk and responsiveness of COPD patients to inhaled corticosteroids (ICS).
Journal Club - Prevalence of AFib with End-Stage COPD
Evaluation of the prevalence of Atrial Fibrillation in Hospital Encounters with End-Stage COPD on Home Oxygen.